BioCentury | Jan 14, 2002
Finance

Hat in Hand?

...BioStratum $28.0M Delsys $26.0M Digital Gene $22.0M OmegaTech $22.0M NetGenics $21.3M Withdrew IPO on 9/01 Framingham Genomic...
BioCentury | Aug 27, 2001
Finance

Money Hunters

...Gene $22.0M OmegaTech $22.0M NetGenics $21.3M Filed for IPO 3/13/00; round of layoffs January '01 Framingham Genomic...
BioCentury | Aug 27, 2001
Finance

Money Hunters

...Gene $22.0M OmegaTech $22.0M NetGenics $21.3M Filed for IPO 3/13/00; round of layoffs January '01 Framingham Genomic...
BioCentury | Jan 2, 2001
Company News

Framingham Genomic, Boston University deal

...factors is being conducted by the university and the National Heart, Lung and Blood Institute. Framingham Genomic Medicine Inc....
BioCentury | Dec 29, 2000
Company News

Framingham Genomic will not receive heart study data

...subscription basis for commercial use, but would have been freely available to not-for-profit scientific researchers. Framingham Genomic...
BioCentury | Jun 26, 2000
Politics, Policy & Law

Bioethics

...understand disease. But obtaining and using such data has raised a debate over ethical issues. Framingham Genomic Medicine Inc....
...up a commercial enterprise based on data obtained using public money, are still being resolved. Framingham Genomic...
...of the original cohort and their spouses. According to Fred Ledley, chief scientific officer at Framingham Genomic...
BioCentury | Jun 26, 2000
Company News

Framingham Genomic drug discovery news

...Boston University founded Framingham Genomic to analyze data from the Framingham Heart Study, an ongoing epidemiological study...
...The study also compiles data on osteoporosis, arthritis, pulmonary disorders, neurological disorders, deafness and diabetes. Framingham Genomic...
...data and analyze associations between the clinical information and the sequence of the human genome. Framingham Genomic...
BioCentury | Jun 19, 2000
Company News

Genomics company to analyze Framingham Heart data

...Boston University founded Framingham Genomic Medicine (Boston, Mass.) to analyze data from the Framingham Heart Study, an...
...relevant to diseases of aging including osteoporosis, arthritis, pulmonary disorders, neurological disorders, deafness and diabetes. Framingham Genomic...
...tools to analyze associations between the clinical information and the sequence of the human genome. Framingham Genomic...
Items per page:
1 - 8 of 8
BioCentury | Jan 14, 2002
Finance

Hat in Hand?

...BioStratum $28.0M Delsys $26.0M Digital Gene $22.0M OmegaTech $22.0M NetGenics $21.3M Withdrew IPO on 9/01 Framingham Genomic...
BioCentury | Aug 27, 2001
Finance

Money Hunters

...Gene $22.0M OmegaTech $22.0M NetGenics $21.3M Filed for IPO 3/13/00; round of layoffs January '01 Framingham Genomic...
BioCentury | Aug 27, 2001
Finance

Money Hunters

...Gene $22.0M OmegaTech $22.0M NetGenics $21.3M Filed for IPO 3/13/00; round of layoffs January '01 Framingham Genomic...
BioCentury | Jan 2, 2001
Company News

Framingham Genomic, Boston University deal

...factors is being conducted by the university and the National Heart, Lung and Blood Institute. Framingham Genomic Medicine Inc....
BioCentury | Dec 29, 2000
Company News

Framingham Genomic will not receive heart study data

...subscription basis for commercial use, but would have been freely available to not-for-profit scientific researchers. Framingham Genomic...
BioCentury | Jun 26, 2000
Politics, Policy & Law

Bioethics

...understand disease. But obtaining and using such data has raised a debate over ethical issues. Framingham Genomic Medicine Inc....
...up a commercial enterprise based on data obtained using public money, are still being resolved. Framingham Genomic...
...of the original cohort and their spouses. According to Fred Ledley, chief scientific officer at Framingham Genomic...
BioCentury | Jun 26, 2000
Company News

Framingham Genomic drug discovery news

...Boston University founded Framingham Genomic to analyze data from the Framingham Heart Study, an ongoing epidemiological study...
...The study also compiles data on osteoporosis, arthritis, pulmonary disorders, neurological disorders, deafness and diabetes. Framingham Genomic...
...data and analyze associations between the clinical information and the sequence of the human genome. Framingham Genomic...
BioCentury | Jun 19, 2000
Company News

Genomics company to analyze Framingham Heart data

...Boston University founded Framingham Genomic Medicine (Boston, Mass.) to analyze data from the Framingham Heart Study, an...
...relevant to diseases of aging including osteoporosis, arthritis, pulmonary disorders, neurological disorders, deafness and diabetes. Framingham Genomic...
...tools to analyze associations between the clinical information and the sequence of the human genome. Framingham Genomic...
Items per page:
1 - 8 of 8